Inflammatory cytokines in TME, such as IFN-ꝩ, IL-1β, IL-6, and TNF, further favorize cancer immune escape by augmenting PD-L1/PD-L2 expression on tumor cells including TNBC [55,56]. The gene discussed is IL1B; the disease is cancer.